Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Stefan Stortecky Added: 2 years ago
AHA 23 — We are joined onsite by Prof Stefan Stortecky (Bern University Hospital, Bern, SE) to discuss the findings of the single centre SPECIAL trial that investigated ultrasound-assisted catheter-directed thrombolysis as compared to surgical pulmonary embolectomy for intermediate high or high risk pulmonary embolism.Questions1. What is the reasoning behind this study?2. What is the patient… View more
Author(s): Andrew SP Sharp , Gilles Lemesle , Start date: Oct 07, 2025
Pulmonary Embolism (PE) remains a leading cause of cardiovascular morbidity and mortality, requiring timely intervention and coordinated multidisciplinary care. This session will provide an in-depth analysis of the current PE treatment landscape, including the latest clinical trial updates (HI-PEITHO, PEERLESS), institutional decision-making workflows and collaborative patient management… View more
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 2 years ago
What should you keep an eye out for at this year's AHA Scientific Sessions?Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, NL) return with their 'View from the Thoraxcenter' preview to highlight late-breaking and featured science trials being presented at this year's AHA Scientific Sessions. Join this dynamic discussion on some of the most anticipated data releases.The… View more
Author(s): Dr Wissam A Jaber Added: 1 year ago
TCT Conference 24 - PEERLESS II shows benefit of large-bore mechanical thrombectomy compared to catheter-directed thrombolysis for intermediate-risk pulmonary embolism (PE) patients.Dr Wissam A Jaber (Emory University Hospital Midtown, US) joins us onsite at TCT Conference to discuss the findings from PEERLESS (NCT06055920; Inari Medical).PEERLESS is a prospective, multicenter, randomized… View more
Author(s): Rick Veasey Added: 1 year ago
ESC Congress 24 — SHAM-PVI study finds pulmonary vein isolation effective in reducing atrial fibrillation (AF) episodes, improving quality of life.We are joined onsite by Dr Rick Veasey (Eastbourne District General Hospital, Eastbourne, UK) to discuss the findings from a SHAM-PVI, a randomized sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation (NCT04272762; East… View more
Author(s): Kazuya Hosokawa , Abe Kotaro Added: 2 years ago
AHA 2023 — Dr Kazuya Hosokawa and Dr Abe Kotaro (Kyushu University Hospital, JP) join us to share the findings of the KABUKI trial (NCT04730037). The aim of KABUKI (Daiichi Sankyo) is to assess whether edoxaban, a direct factor Xa inhibitor, is noninferior to warfarin in preventing worsening of chronic thromboembolic pulmonary hypertension (CTEPH).This investigator-initiated, multicenter, phase 3… View more
Job title: Head of Invasive Cardiology (Invasve Cardiology)
Invasive Cardiologist and Angiologist at University of Szeged, Internal Medicine Department and at Semmelweis University, Cardiac and Vascular Center. Head of Invasive Cardiology and Angiology at University of Szeged, Internal Medicine Department. Past president of the Hungarian Association of Cardio-Vascular Interventions. He is expert in doing complex coronary (CTO, LM, rotational atherectomy)… View more
Job title: Interventional Cardiologist
Sylwia Sławek-Szmyt is an Assistant Professor and Consultant Cardiologist at the Department of Cardiology, Poznan University of Medical Sciences, Poland, with a focus on interventional cardiology and pulmonary embolism care. She leads the outpatient clinic for patients after pulmonary embolism and performs a wide range of catheter-based coronary, structural, and pulmonary vascular interventions… View more